FDA Approves Wockhardt’s Tamsulosin Capsules

[jayanthi mandhalapu]

The US Food and Drug Administration has approved the marketing of Tamsulosin Hydrochloride capsules by Wockhardt, a drug manufacturer.

Tamsulosin capsules are generally used for the treatment of non-cancerous enlargement of prostate, medically termed the benign prostatic hyperplasia.

Tamsulosin, the generic name for the brand Flomax, is being developed by Japanese drug major Astellas and marketed in the US by Boehringer Ingelheim.

Wokhardt has been given the patent for marketing the drug till April 27, 2010. The product will be soon be made available by the drug major.

No other company has got the USFDA sanction for the Tamsulosin capsule of 0.4mg strength, a company spokesperson claimed.

He said the total market for Tamsulosin capsules in the US is about $1,650 million.